Key facts
- Predictably Human’s last known valuation is $8.3M (Jan 2025).
- It has raised $7.9M across 2 recorded rounds; the latest was Seed Round ($1.3M) in Dec 2024.
- Notable investors include Capital Factory, Connecticut Innovations, Scale Good Fund, Cava Capital.
- Predictably Human has filed 2 Form Ds with the SEC since 2021, most recently Jan 2025 ($1.3M sold to 7 investors).
- Status: Privately Held (backing).
- ·Post-money valuations for all 2 rounds
- ·The complete investor list — 4 names
- ·Watchlist + deal alerts for Predictably Human
Funding rounds
2 roundsAbout Predictably Human
Provider of drug delivery and precision therapeutics intended for outcomes in behavioral-based medical conditions. The company offers a precision drug delivery device, a digital application and a configurable therapeutic engine to provide a precision drug dose, enabling patients with a personalized approach to behavioral modification with remote monitoring for addiction treatments and support for chronic conditions.
- Sector
- Healthcare
- HQ
- Darien, CT, United States
- Founded
- 2020
- Employees
- 8
- Website
- predictablyhuman.com/
- Ownership
- Privately Held (backing)
Predictably Human doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Predictably Human shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Predictably Human in its N-PORT filings yet. We sweep new filings monthly.